학술논문

Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder
Document Type
article
Source
Biological Psychiatry. 89(5)
Subject
Medical Biochemistry and Metabolomics
Biomedical and Clinical Sciences
Intellectual and Developmental Disabilities (IDD)
Digestive Diseases
Prevention
Behavioral and Social Science
Mental Health
Pediatric
Clinical Research
Brain Disorders
Autism
Aetiology
2.1 Biological and endogenous factors
Mental health
Animals
Autism Spectrum Disorder
Feces
Gastrointestinal Microbiome
Mice
Pilot Projects
Plasma
ASD
Autism spectrum disorder
Fecal metabolites
Metabolomics
Mitochondrial dysfunction
Phenolic metabolites
Plasma metabolites
Steroid hormones
Biological Sciences
Medical and Health Sciences
Psychology and Cognitive Sciences
Psychiatry
Biological sciences
Biomedical and clinical sciences
Psychology
Language
Abstract
BackgroundAutism spectrum disorder (ASD) is a neurodevelopmental condition with hallmark behavioral manifestations including impaired social communication and restricted repetitive behavior. In addition, many affected individuals display metabolic imbalances, immune dysregulation, gastrointestinal dysfunction, and altered gut microbiome compositions.MethodsWe sought to better understand nonbehavioral features of ASD by determining molecular signatures in peripheral tissues through mass spectrometry methods (ultrahigh performance liquid chromatography-tandem mass spectrometry) with broad panels of identified metabolites. Herein, we compared the global metabolome of 231 plasma and 97 fecal samples from a large cohort of children with ASD and typically developing control children.ResultsDifferences in amino acid, lipid, and xenobiotic metabolism distinguished ASD and typically developing samples. Our results implicated oxidative stress and mitochondrial dysfunction, hormone level elevations, lipid profile changes, and altered levels of phenolic microbial metabolites. We also revealed correlations between specific metabolite profiles and clinical behavior scores. Furthermore, a summary of metabolites modestly associated with gastrointestinal dysfunction in ASD is provided, and a pilot study of metabolites that can be transferred via fecal microbial transplant into mice is identified.ConclusionsThese findings support a connection between metabolism, gastrointestinal physiology, and complex behavioral traits and may advance discovery and development of molecular biomarkers for ASD.